BBC celebrates 400th anniversary of the publication of Shakespeare’s ‘First Folio’ with ambitious pan-BBC season

    November marks 400 years since
arguably the greatest work of English literature
was created, the ‘First Folio’, published seven
years after the death of William Shakespeare
[5] and without which much of his work would
have been lost for future generations to enjoy
today.
    The BBC is celebrating this
extraordinary anniversary with an ambitious
[10] season of content across TV, Radio, BBC iPlayer
& BBC Sounds exploring why, 400 years on,
Shakespeare's relevance and influence is as
strong as ever. A wealth of programming
featuring major actors and leading experts,
[15] including new documentaries, performance, 

music, drama, comedy, news coverage and the
best of the BBC archive, as well as special items
on flagship BBC shows, will celebrate the man,
his world and his timeless writing.
[20]    Suzy Klein, Head of BBC Arts and
Classical TV, says: “Shakespeare lived in a
dangerous age of plague, violence, vicious
rivalries and political assassinations and his
very survival is something of a miracle. His work
[25] was almost lost to history, and without the First
Folio being published in 1623, eighteen of his
greatest plays would have been lost forever.
We would have none of those immortal
characters such as Cleopatra and Marc
[30] Anthony, Macbeth or Malvolio, Prospero and
Ariel. Shakespeare changed the way we talk,
the words we use, our films, books,
catchphrases and memes, the very way we
think – and yet we know very little about him.
[35] This major new season pieces together the
clues from his life and work to reveal the
driving forces behind the glover's son from
Stratford upon Avon who became the greatest
writer that ever lived.”
[40]    Charlotte Moore, BBC Chief Content
Officer, says: “The BBC has a rich history of
showcasing Shakespeare and bringing his works
alive to successive generations. The 400th
anniversary of the publication of the First Folio
[45] is an important opportunity to build on this
legacy with an ambitious array of programming
across the BBC celebrating the genius of our
greatest writer. With documentaries,
performance, music, drama, comedy and
[50] educational content as well as the very best of
the BBC’s extraordinary archive, this season
demonstrates our commitment to offering
audiences programming they wouldn’t find
anywhere else.”
[55]    The centrepiece of the season is a
gripping three-part documentary series for BBC
Two and iPlayer, Shakespeare: Rise of a
Genius, featuring an A-list cast of actors,
including Dame Judi Dench, Dame Helen
[60] Mirren, Brian Cox, Adrian Lester, Lolita
Chakrabarti, Martin Freeman and Jessie
Buckley, alongside academics and writers James
Shapiro, Jeanette Winterson, Lucy Jago , Jeremy
O’Harris and Ewan Fernie - who provide fresh
[65] insights into the incredible story of our greatest
writer, the place and time he inhabited and the
work he produced. The series is made by 72
Films (a Fremantle company), the award-

winning producers of Rise of the Nazis,
[70] Elizabeth’s Secret Agents.
    Contributing to the series, Dame Judi
Dench, says: “His understanding of everything,
of love, of anger, of jealousy, of rage, 

melancholy – who did it better, who has ever
[75] done it better? I wish I’d met him, oh I wish I’d
met him.”
    Accompanying the series, BBC Four
will feature a star-studded selection of archive
performances with specially filmed
[80] introductions from David Tennant on
Hamlet, Sir Richard Eyre on King
Lear, Dame Janet Suzman on Wars of the
Roses, Gregory Doran on the Shakespeare Gala
from the RSC, Russell T Davies on A
[85] Midsummer Night’s Dream, Dame Helen
Mirren on As You Like It, Hugh Quarshie on
Othello and Steven Berkoff on Hamlet at
Elsinore.
    BBC Four will be showing a number of
[90] acclaimed performances of Shakespeare's
greatest plays including Hamlet from the Bristol
Old Vic featuring rising star Billy Howle in the
title role; Henry V from Shakespeare’s Globe
with Jamie Parker in the lead role; the
[95] RSC’s Henry VI Part 1 with Sir Antony Sher in
the role of Falstaff; and the RSC’s Much Ado
About Nothing.
    On BBC Radio 4 – Dame Judi Dench,
one of Britain’s foremost Shakespearean actors
[100] will be John Wilson’s guest on This Cultural
Life. A special edition of Front Row: 1623
Review Show will see the panel and guests go
back in time to review the music, poems and
plays from the year that the First Folio was
[105] published. In addition, First Folio, a new semi

fictionalised comic drama tells the story of the
creation of the first book of Shakespeare’s
plays.
    Radio 3 will dedicate a day exclusively
[110] to music inspired by Shakespeare, while Drama
on 3: The Hamlet Season will feature three
contemporary dramas based on Hamlet, the
Shakespearean play that has been put on the
most times around the world.
[115]    In addition, BBC Teach will publish a
collated collection of resources for primary and
secondary schools to mark the anniversary,
including a new nine-part video animation of
Romeo and Juliet for primary schools.

Adapted from: https://www.bbc.com/mediacentre/2023/shakespeare-first-folio-400-anniversary

Leia o texto I para responder a questão

Texto I
THE "13 REASONS WHY" ACTORS HAD THERAPY DOGS TO HELP WITH EMOTIONAL SCENES
By Hannah Orenstein - Apr 17, 2017

    “13 Reasons Why” doesn't shy away from tackling heavy issues like bullying, rape, and suicide. But bringing such dark stories to life can take a toll on actors, which is why the cast had access to cute, cuddly therapy dogs while filming the show.
    "They had therapy dogs on set," Dylan Minnette, who played Clay, told PopSugar. "There was a puppy per hour. They really tried to help out. The puppies helped." According to the Alliance of Therapy Dogs, the pups are "on a mission of sharing smiles and joy."
    Dylan also acknowledged that Katherine Langford, who played Hannah, had the most intense experience of them all. "She had the brunt of the emotional stuff," he continued. "I mean, we all have very emotional parts, but this is about her character." In the same interview, Katherine acknowledged the intensity of her character's role and explained why it was so important to bring these tough scenes to life.
    "We always read a new script at a table read, and once we hit episode nine, there was silence," she said. "That's when we realized what we were doing was important. That's the moment that's kind of ingrained in my head as, 'This is really important.' We cover so many intense issues. I feel like so much of Hannah's life, especially the last five episodes, is so tragic that you just have to put that shock aside and get through it. It's only been after the show and after wrapping that I've gone, wow, we really did handle some really heavy stuff. I'm really proud of how we handle it, because as you said we don't shy away from them."
Fonte: <http://www.seventeen.com/celebrity/movies-tv/news/a46489/the-13-reasons-why-actors-had-therapy-dogs/> Acesso: 22/05/2017.

Arkansas man receives world's first eye transplant

Aaron James lost his nose, mouth and left eye in a work-related accident. Surgeons in New York successfully performed the reconstruction that included a whole-eye implant. His vision was not restored, but the first-of-its-kind procedure may help advance transplant medicine.

"If some form of vision restoration occurred, it would be wonderful, but... the goal was for us to perform the technical operation," said the chief surgeon, Dr Eduardo Rodriguez.

BBC NEWS. Arkansas man receives world?s first eye transplant. 9 nov. 2023. Disponível em: . Acesso em: 23 nov. 2023.

Susan Calvin had been born in the year 1982, they said, which made her seventy five now. Everyone knew that. Appropriately enough, U. S. Robot and Mechanical Men, Inc. was seventy-five also, since it had been in the year of Dr. Calvin’s birth that Lawrence Robertson had first taken out incorporation papers for what eventually became the strangest industrial giant in man’s history. Well, everyone knew that, too. (…)

She went back to her desk and sat down. She didn’t need expression on her face to look sad, somehow.

“How old are you?” she wanted to know.

“Thirty-two,” I said.

“Then you don’t remember a world without robots.

There was a time when humanity faced the universe alone and without a friend. Now he has creatures to help him; stronger creatures than himself, more faithful, more useful, and absolutely devoted to him. Mankind is no longer alone. Have you ever thought of it that way?”

“I’m afraid I haven’t. May I quote you?”

“You may. To you, a robot is a robot. Gears and metal; electricity and positrons. Mind and iron! Human-made! If necessary, human-destroyed! But you haven’t worked with them, so you don’t know them. They’re a cleaner, better breed than we are.”

(ASIMOV, I. I, Robot. Greenwich, Conn: Fawcett Publications,1950. p. 2-3.)

Leia o texto a seguir e responda à questão.

Pharmaceutical industry gets high on fat profits

Pharmaceutical companies have developed the vast majority of medicines known to humankind, but they have profited handsomely from doing so, and not always by legitimate means. Drug companies have been accused of, and admitted to, far worse practices than making money. Until recently, paying bribes to doctors to prescribe their drugs was commonplace at big pharmas, although the practice is now generally frowned upon and illegal in many places. The rules on gifts, educational grants and sponsoring lectures, for example, are less clear cut, and these practices remain commonplace in the US. Indeed a recent study found that doctors in the US receiving payments from pharma companies were twice as likely to prescribe their drugs. This all may change when new rules in the US and UK will force doctors to disclose all gifts and payments made by the industry. Drug companies have also been accused of colluding with chemists to overcharge for their medicines and of publishing trial data that highlight the positive at the expense of the negative. The rewards are so great, it would seem, that pharma companies have continually been prepared to push the boundaries of legality. No wonder, then, that the World Health Organisation (WHO) has talked of the “inherent conflict” between the legitimate business goals of the drug companies and the medical and social needs of the wider public. Indeed the Council of Europe is launching an investigation into “protecting patients and public health against the undue influence of the pharmaceutical industry”. It will look at “particular practices such as sponsoring health professionals by the industry ... or recourse by public health institutions to the knowledge of highly specialised researchers on the pay-rolls of industry”. No matter what the outcome of such investigations, however, the pharmaceutical industry is facing fundamental change, as the traditional model of developing drugs breaks down due to rising costs and scientific advances. The cosy world of big pharmaceuticals is under threat like never before.

(Adaptado de: ANDERSON, R. Pharmaceutical industry gets high on fat profits. BBC News. Online. 6 nov. 2014. Disponível em: http://www.bbc.com/news/business-28212223. Acesso em: 12 jun. 2015.)